15-48434593-C-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_000138.5(FBN1):c.6616+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000138.5 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Marfan syndrome Pathogenic:2
- -
PM2, PS7, PP4 -
not provided Pathogenic:1
The c.6616+1 G>A variant has been reported previously in two individuals with Marfan syndrome(Attanasio et al., 2008; Proost et al., 2015). This variant destroys the canonical splice donor site inintron 54 and is predicted to cause abnormal gene splicing. This variant is predicted to lead to eitheran abnormal message that is subject to nonsense-mediated mRNA decay, or to an abnormal proteinproduct if the message is used for protein translation. Other splice site variants in the FBN1 gene,including two affecting the same splice donor site (c.6616+1 G>T; c.6616+2 T>A), have beenreported in HGMD in association with Marfan syndrome (Stenson et al., 2014). Furthermore, thec.6616+1 G>A variant was not observed in approximately 6,500 individuals of European and AfricanAmerican ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benignvariant in these populations. In summary, c.6616+1 G>A in the FBN1 gene is interpreted as a pathogenic variant. -
Marfan syndrome;C4707243:Familial thoracic aortic aneurysm and aortic dissection Pathogenic:1
This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 419595). Disruption of this splice site has been observed in individual(s) with Marfan syndrome (PMID: 19293843, 25907466). In at least one individual the variant was observed to be de novo. This sequence change affects a donor splice site in intron 54 of the FBN1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in FBN1 are known to be pathogenic (PMID: 17657824, 19293843). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at